These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

81 related articles for article (PubMed ID: 858238)

  • 1. Narcotic antagonist treatment of addict parolees--the failure of an effective approach.
    Hanlon TE; McCabe OL; Savage C; Kurland AA
    Compr Psychiatry; 1977; 18(3):211-9. PubMed ID: 858238
    [No Abstract]   [Full Text] [Related]  

  • 2. Contingent naloxone treatment of the narcotic addict: a pilot study.
    Kurland AA; McCabe L; Hanlon T
    Int J Addict; 1976; 11(1):131-42. PubMed ID: 1254364
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Naloxone in the treatment of the young heroin abuser.
    Pierson PS; Rapkin RM; Kleber HD
    Am J Drug Alcohol Abuse; 1974; 1(2):243-52. PubMed ID: 4467727
    [No Abstract]   [Full Text] [Related]  

  • 4. Contingent naloxone (N-allylnoroxymorphone) treatment of the paroled narcotic addict.
    Kurland AA; McCabe L; Hanlon TE
    Int Pharmacopsychiatry; 1975; 10(3):157-68. PubMed ID: 1099047
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Offer of a quick fix.
    Gould M
    Nurs Stand; 2011 Nov 16-22; 26(11):24-5. PubMed ID: 22204109
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clinical experience with naltrexone.
    O'Brien CP; Greenstein RA; Mintz J; Woody GE
    Am J Drug Alcohol Abuse; 1975; 2(3-4):365-77. PubMed ID: 1227298
    [No Abstract]   [Full Text] [Related]  

  • 7. The use of cyclazocine in treating narcotic addicts in a low-intervention setting.
    Kleber H; Kinsella JK; Riordan C; Greaves S; Sweeney D
    Arch Gen Psychiatry; 1974 Jan; 30(1):37-42. PubMed ID: 4808735
    [No Abstract]   [Full Text] [Related]  

  • 8. Strategies for preventing heroin overdose.
    Sporer KA
    BMJ; 2003 Feb; 326(7386):442-4. PubMed ID: 12595388
    [No Abstract]   [Full Text] [Related]  

  • 9. Naltrexone: the clinical investigator's dilemma.
    Ling W
    NIDA Res Monogr; 1978; (19):308-14. PubMed ID: 106297
    [No Abstract]   [Full Text] [Related]  

  • 10. A controlled comparison of cyclazocine and naloxone treatment of the paroled narcotic addict.
    Hanlon TE; McCabe OL; Savage C; Kurland AA
    Int Pharmacopsychiatry; 1975; 10(4):240-50. PubMed ID: 765293
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Analysis and modification of opiate reinforcement.
    Meyer RE; McNamee HB; Mirin SM; Altman JL
    Int J Addict; 1976; 11(3):467-84. PubMed ID: 184053
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clinical evaluation of naltrexone treatment of opiate-dependent individuals. Report of the National Research Council Committee on Clinical Evaluation of Narcotic Antagonists.
    Arch Gen Psychiatry; 1978 Mar; 35(3):335-40. PubMed ID: 365122
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The distribution of naloxone to heroin users.
    Darke S; Hall W
    Addiction; 1997 Sep; 92(9):1195-9. PubMed ID: 9374020
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Regarding naltrexone for probationers and parolees.
    Stancliff S
    J Subst Abuse Treat; 2007 Mar; 32(2):217-8; author reply 218-9. PubMed ID: 17306730
    [No Abstract]   [Full Text] [Related]  

  • 15. Heroin and naloxone.
    Lagoy A
    Am J Nurs; 2014 Oct; 114(10):12. PubMed ID: 25251107
    [No Abstract]   [Full Text] [Related]  

  • 16. A stepped care strategy using buprenorphine and methadone versus conventional methadone maintenance in heroin dependence: a randomized controlled trial.
    Kakko J; Grönbladh L; Svanborg KD; von Wachenfeldt J; Rück C; Rawlings B; Nilsson LH; Heilig M
    Am J Psychiatry; 2007 May; 164(5):797-803. PubMed ID: 17475739
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prescription naloxone: a novel approach to heroin overdose prevention.
    Sporer KA; Kral AH
    Ann Emerg Med; 2007 Feb; 49(2):172-7. PubMed ID: 17141138
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Opiate antagonists and the modification of heroin self-administration behavior in man: an experimental study.
    Altman JL; Meyer RE; Mirin SM; McNamee HB
    Int J Addict; 1976; 11(3):485-99. PubMed ID: 184054
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A behavioral paradigm for the evaluation of narcotic antagonists.
    Meyer RE; Mirin SM; Altman JL; McNamee HB
    Arch Gen Psychiatry; 1976 Mar; 33(3):371-7. PubMed ID: 944026
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Caution with naloxone use in asthmatic patients.
    Allegretti PJ; Bzdusek JS; Leonard J
    Am J Emerg Med; 2006 Jul; 24(4):515-6. PubMed ID: 16787825
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.